Crohn's and Colitis Awareness Week runs from Monday, December 1, to Sunday, December 7. Here, one person living with Crohn's ...

European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg ...

Sharecare, the digital health enablement company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it has won 22 Digital ...

Instructor Wendy Broughton, seated at left, works with students in the health sciences track of Bentonville public schools’ Ignite program on Nov. 5, 2025, in Bentonville, Ark. The program—which ...

The "Ignite" career-track program at Bentonville Public Schools in Arkansas has added an AI twist, helping students ...

Mirikizumab (Omvoh) is effective in inducing a clinical response in adults with moderate-to-severe ulcerative colitis and ...

Ulcerative colitis (UC) is one of the most common inflammatory bowel diseases, a lifelong condition that can cause chronic ...

Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...

Here are some tips to manage irritable bowel disease (IBD) and protect your stomach during the holidays and beyond.

A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal ...

A gut microbe secretes macrophage-targeting factors, rendering the intestinal layer vulnerable to ulcerative colitis, ...

A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new ...